US Stock MarketDetailed Quotes

ZVSAW ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM)

Watchlist
  • 0.070
  • 0.0000.00%
Close Dec 20 16:00 ET
0Market Cap0.00P/E (TTM)

ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Total revenue
0
0
Operating revenue
--0
--0
Cost of revenue
Gross profit
Operating expense
-34.89%7.7M
11.83M
Selling and administrative expenses
4.03%5.58M
--5.36M
-General and administrative expense
4.03%5.58M
--5.36M
Research and development costs
-67.16%2.12M
--6.47M
Operating profit
34.89%-7.7M
-11.83M
Net non-operating interest income expense
-59.04%-821.37K
-516.45K
Non-operating interest expense
59.04%821.37K
--516.45K
Other net income (expense)
232.35%441.58K
-333.66K
Gain on sale of security
168.36%228.1K
---333.66K
Special income (charges)
--213.48K
--0
-Less:Other special charges
---213.48K
----
Income before tax
36.26%-8.08M
-12.68M
Income tax
Net income
36.26%-8.08M
-12.68M
Net income continuous Operations
36.26%-8.08M
---12.68M
Minority interest income
Net income attributable to the parent company
36.26%-8.08M
-12.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
36.26%-8.08M
-12.68M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
(FY)Dec 31, 2021(FY)Dec 31, 2020
Total revenue 00
Operating revenue --0--0
Cost of revenue
Gross profit
Operating expense -34.89%7.7M11.83M
Selling and administrative expenses 4.03%5.58M--5.36M
-General and administrative expense 4.03%5.58M--5.36M
Research and development costs -67.16%2.12M--6.47M
Operating profit 34.89%-7.7M-11.83M
Net non-operating interest income expense -59.04%-821.37K-516.45K
Non-operating interest expense 59.04%821.37K--516.45K
Other net income (expense) 232.35%441.58K-333.66K
Gain on sale of security 168.36%228.1K---333.66K
Special income (charges) --213.48K--0
-Less:Other special charges ---213.48K----
Income before tax 36.26%-8.08M-12.68M
Income tax
Net income 36.26%-8.08M-12.68M
Net income continuous Operations 36.26%-8.08M---12.68M
Minority interest income
Net income attributable to the parent company 36.26%-8.08M-12.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 36.26%-8.08M-12.68M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data